Literature DB >> 71562

Plasma-prolactin and cimetidine.

M Petrillo, A Prada, G B Porro, M Bevilacqua, V Raggi, G Norbiato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71562     DOI: 10.1016/s0140-6736(77)90260-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Stimulation of prolactin release by intravenous cimetidine: a dose-response study.

Authors:  R Caldara; L Bierti; C Barbieri; M Cambielli; M Romussi; C Ferrari
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

Review 3.  Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

4.  Prolactin responses to cimetidine.

Authors:  W L Burland; R I Gleadle; R M Lee; D Rowley-Jones; G V Groom
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

Review 5.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  Gynaecomastia associated with cimetidine.

Authors:  R W Spence; L R Celestin
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

7.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.